JAVIER
VAQUERO RODRÍGUEZ
Investigador
José Juan
García Marín
Catedrático de Universidad
Publicaciones en las que colabora con José Juan García Marín (12)
2023
-
Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance
Nature Reviews Gastroenterology and Hepatology, Vol. 20, Núm. 7, pp. 462-480
2019
-
Signalling networks in cholangiocarcinoma: Molecular pathogenesis, targeted therapies and drug resistance
Liver International, Vol. 39, Núm. S1, pp. 43-62
2018
-
MicroRNA-506 promotes primary biliary cholangitis–like features in cholangiocytes and immune activation
Hepatology, Vol. 67, Núm. 4, pp. 1420-1440
2016
-
Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Nature Reviews Gastroenterology and Hepatology, Vol. 13, Núm. 5, pp. 261-280
2013
-
Activation of the nuclear receptor FXR enhances hepatocyte chemoprotection and liver tumor chemoresistance against genotoxic compounds
Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1833, Núm. 10, pp. 2212-2219
-
Differential activation of the human farnesoid X receptor depends on the pattern of expressed isoforms and the bile acid pool composition
Biochemical Pharmacology, Vol. 86, Núm. 7, pp. 926-939
-
Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib
Hepatology, Vol. 58, Núm. 3, pp. 1065-1073
-
FXR-dependent and -independent interaction of glucocorticoids with the regulatory pathways involved in the control of bile acid handling by the liver
Biochemical Pharmacology, Vol. 85, Núm. 6, pp. 829-838
2012
-
Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta
Molecular Pharmacology, Vol. 81, Núm. 2, pp. 273-283
-
Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins
Molecular Pharmaceutics, Vol. 9, Núm. 9, pp. 2565-2576
-
No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors
Molecular Pharmaceutics, Vol. 9, Núm. 6, pp. 1693-1704
-
Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy
Pharmacological Research, Vol. 66, Núm. 5, pp. 419-427